Exagen INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
XGN
Exagen INCExagen Inc. has released its 2026 proxy statement detailing the upcoming annual meeting agenda, director elections, and executive compensation.
NASDAQ
XGN
Exagen INCExagen Inc. will hold its annual meeting on June 10, 2025, to elect directors, ratify the appointment of auditors, and vote on executive compensation.
NASDAQ
XGN
Exagen INCExagen Inc. will hold its 2025 Annual Meeting of Stockholders on June 10, 2025, to elect directors, ratify the appointment of its accounting firm, and vote on executive compensation matters.
NASDAQ
XGN
Exagen INCExagen Inc. has filed a definitive proxy statement with the Securities and Exchange Commission.
NASDAQ
XGN
Exagen INCDEF 14A: Exagen Inc. Announces Annual Meeting of Stockholders, Director Nominations, and Auditor Ratification
Exagen Inc. will hold its Annual Meeting of Stockholders on June 10, 2024, to elect directors and ratify the appointment of its independent auditor.